Delivery Order SPE2DB24D1021-SPE2DB25FETUB

Award Date 2/4/25
Potential Completion Date 2/26/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 0.9 ML Pfizer COVID-19 vaccines for the 2023-2024 period under the Emergency Use Authorization (EUA). The contract has a ceiling value of $1,777.70 and is a firm fixed-price contract. The place of performance is Conshohocken, PA. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Pfizer COVID-19 vaccine doses from 2024-2025 under the Emergency Use Authorization (EUA). The contract has a ceiling value of $3,389.40 and a completion date of February 2025. It is not designated as a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of 0.9 ML doses of Pfizer's COVID-19 vaccine for the 2023-2024 period, under an Emergency Use Authorization (EUA). The contract has a firm fixed price of $25,691.25 and a completion date of April 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award is a delivery order valued at $1,129.80 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 0.9ML doses of the Pfizer COVID-19 vaccine for the 2024-2025 period, under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of January 3, 2025 and is a firm fixed-price arrangement. This delivery order is part...
This is a $1,069.25 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,564,309,714 units of the Pfizer COVID-19 vaccine (0.9 mL) under an Emergency Use Authorization (EUA) over a period of 6 months to 4 years. The contract is a Firm Fixed Price (FFP) arrangement with no set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,129.80, is for the procurement of Pfizer COVID-19 vaccine doses to support vaccine requirements from 2024 to 2025, with a potential treatment window of 6 months to 4 years. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,092.06 firm fixed price contract is for the delivery of Pfizer COVID-19 vaccine doses from 2024 to 2025, with a period of performance ending on November 29, 2024. The contract was not set aside for any specific business type. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a $1,525.97 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 0.9ml Pfizer COVID-19 vaccine doses for the 2023-2024 period under the Emergency Use Authorization (EUA). The contract has an ultimate completion date of May 10, 2024. There is no set-aside designation noted for this award. Amerisourcebergen holds a larger $999,999,999.00 Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $1,227.33, is for the delivery of Pfizer COVID-19 vaccine doses with a 6-month to 4-year shelf life under the Emergency Use Authorization (EUA). The contract does not have a set-aside designation. AmerisourceBergen Drug Corp...
This is a delivery order award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,525.97 firm-fixed-price contract is for the supply of the Pfizer COVID-19 vaccine under the Emergency Use Authorization (EUA) for the 2023-2024 period, with an ultimate completion date of April 22, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
  • SPE2DB24D1021
    Indefinite Delivery Contract
  • SPE2DB24D1021-SPE2DB25FETUB
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the delivery of Pfizer COVID-19 vaccines in the 2024-2025 timeframe. The contract has a ceiling value of $1,129.80 and is for 0.9 ml dosages under the Emergency Use Authorization (EUA). The contract is for a firm fixed price and does not have any set-aside designations. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies medical products to federal government agencies, including the military healthcare system. This contract award is part of a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/6/25, 11:53 AM